Search

Your search keyword '"Ciss, Mounerou"' showing total 3 results
Start Over Author "Ciss, Mounerou"
3 results on '"Ciss, Mounerou"'

1. The Senegalese Antiretroviral Access Initiative : an introduction

Author

Ndoye, Ibra, Taverne, Bernard, Desclaux, Alice, Isabelle, Lanièce, Egrot, Marc, Delaporte, Eric, Sow, Papa-Salif, Mboup, Souleymane, Sylla, Omar, Ciss, Mounerou, Comité National de Lutte contre le Sida du Sénégal (CNLS), Ministère de la santé-CNLS, Institut de Recherche pour le développement, UR036, Centre de Recherche Cultures, Santé, Sociétés (JE 2424) (CReCSS), Université Paul Cézanne - Aix-Marseille 3-JE2424, coopération française, Centre de Recherche Cultures, Santé, Société (CReCSS), Université Paul Cézanne - Aix-Marseille 3, Service des Maladies Infectieuses et Tropicales (SMIT), CHU de Fann, Alice Desclaux, Isabelle Lanièce, Ibra Ndoye, Bernard Taverne, ANRS, UNAIDS, WHO, Egrot, Marc, and Alice Desclaux, Isabelle Lanièce, Ibra Ndoye, Bernard Taverne

Subjects
[SDV.MP.VIR] Life Sciences [q-bio]/Microbiology and Parasitology/Virology, [SHS.ANTHRO-SE] Humanities and Social Sciences/Social Anthropology and ethnology, [SDV.MP.VIR]Life Sciences [q-bio]/Microbiology and Parasitology/Virology, [SHS] Humanities and Social Sciences, [SHS.ANTHRO-SE]Humanities and Social Sciences/Social Anthropology and ethnology, ComputingMilieux_MISCELLANEOUS, [SHS]Humanities and Social Sciences
Abstract

International audience

Published
2004

2. The circulation of antiretrovirals in Senegal

Author

Egrot, Marc, Taverne, Bernard, Ciss, Mounerou, Ndoye, Ibra, Centre de Recherche Cultures, Santé, Société (CReCSS), Université Paul Cézanne - Aix-Marseille 3, VIH/SIDA et maladies associées, Université Montpellier 1 (UM1), Comité National de Lutte contre le Sida du Sénégal (CNLS), Ministère de la santé-CNLS, ANRS, Alice Desclaux, Isabelle Lanièce, Ibra Ndoye, Bernard Taverne, and ANRS, UNAIDS, WHO

Subjects
antiretroviral, [SDV.MP.VIR]Life Sciences [q-bio]/Microbiology and Parasitology/Virology, pharmaceutical, anthropology, [SHS.ANTHRO-SE]Humanities and Social Sciences/Social Anthropology and ethnology, ComputingMilieux_MISCELLANEOUS, Senegal, aids, [SHS]Humanities and Social Sciences
Abstract

International audience

Published
2004

3. Access to antiretroviral drugs and AIDS management in Senegal

Author

Desclaux, Alice, Ciss, Mounerou, Taverne, Bernard, Sow, Papa Salif, Egrot, Marc, Faye, Mame Awa, Isabelle, Lanièce, Sylla, Omar, Delaporte, Eric, Ndoye, Ibrahima, Laboratoire d'Ecologie Humaine et d'Anthropologie, Université Paul Cézanne - Aix-Marseille 3, Laboratoire National, Ministère de la santé, Dakar, Institut de Recherche pour le développement, UR036, Centre Hospitalo-Universitaire de Fann, Dakar, coopération française, Programme National de Lutte contre le sida, Université de Montpellier (UM), Katzenstein, D. (ed.), Laga, M. (ed.), and Moatti, J.P. (ed.)

Subjects
TRAITEMENT MEDICAL, ACCES AUX SOINS, ANTIRETROVIRAUX, SIDA, COUT, [SDV.MP.VIR]Life Sciences [q-bio]/Microbiology and Parasitology/Virology, VIRUS, MEDICAMENT, [SHS.ANTHRO-SE]Humanities and Social Sciences/Social Anthropology and ethnology, health care economics and organizations, [SHS]Humanities and Social Sciences
Abstract

International audience; Objectives Description and analysis of the Senegalese Antiretroviral Drug Access Initiative (ISAARV), the first governmental highly active antiretroviral therapy (HAART) treatment programme in Africa, launched in 1998.Methods and results ISAARV was initially an experimental project designed to evaluate the feasibility, efficacy and acceptability of HAART in an African context. It was based on four principles: collective definition of the strategy, with involvement of the health professionals who would be called on to execute the programme; matching the objectives to available means (gradual enrollment according to drug availability); monitoring by several research programmes; and ongoing adaptation of treatment and follow-up according to the latest international recommendations.Persons qualifying for antiretroviral (ARV) therapy are selected on the basis of immunological and clinical criteria, regardless of economic and social considerations. A system of subsidies was created to favor access to ARV. Following the ARV price reductions that occurred in November 2000, 100% subsidies were created for the poorest participants. Optimal adherence was ensured by monthly follow-up by pharmacists and support groups held by social workers and patient associations. The chosen supply and distribution system allowed drug dispensing to be strictly controlled.Conclusion The ISAARV programme demonstrates that HAART can be successfully prescribed in Africa. This experience has served as the basis for the creation of a national treatment programme in Senegal planned to treat 7000 patients by 2006.

Published
2003

Catalog

Books, media, physical & digital resources
See catalog results